Form 4 for IBRX ImmunityBio, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001830328-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2025-12-31 | IBRX | Adcock Richard | CEO, Pres, Dir | F - Tax | $1.98 | -17.5K | 351.4K | -5% | -$34.7K |
| D | 2026-01-05 | 2025-12-31 | IBRX | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +34.5K | 368.9K | +10% | $0 |
| D | 2026-01-05 | 2025-12-31 | IBRX | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | -34.5K | 51.7K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | F | D | 17,510 | $1.98 | 351,391 | D | — | — | (F2) On December 31, 2025, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 30, 2025 was the settlement price used to calculate the shares withheld. |
| 2 | Common | Common Stock | 2025-12-31 | M | A | 34,483 | $0.00 | 368,901 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. |
| 3 | Derivative | Restricted Stock Units | 2025-12-31 | M | D | 34,483 | $0.00 | 51,731 | D | — · — to — | 34,483 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. (F3) Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2025; and the remaining RSUs will vest on December 31, 2026. |